Breaking
Stocks

Stock Market News & Analysis

Latest stock picks, earnings reports, IPOs, and equity market analysis for investors.

Micron Commits Up to $3B to US Chip Supply Chain; Stock Rises 6% on AI Demand Optimism
Stocks
Micron Commits Up to $3B to US Chip Supply Chain; Stock Rises 6% on AI Demand Optimism
Micron Technology plans to invest up to $3 billion to expand the US semiconductor supply chain, including $500 million i
PepsiCo Q2 Revenue Tops Estimates as North America Demand Weakens
Stocks
PepsiCo Q2 Revenue Tops Estimates as North America Demand Weakens
PepsiCo beat Q2 revenue estimates at $24.18B, but warned North America demand remains pressured by inflation, sending sh
FTSE 100 Slips 0.6% as AstraZeneca Plunges 9.2% on Failed Wainua Trial
Stocks
FTSE 100 Slips 0.6% as AstraZeneca Plunges 9.2% on Failed Wainua Trial
The FTSE 100 declined 0.6% on Thursday, dragged by a 9.2% plunge in AstraZeneca after its nerve disease drug Wainua fail
Trident Digital Tech Takes Strategic Stake in AI Firm Digital Innovations Group
Stocks
Trident Digital Tech Takes Strategic Stake in AI Firm Digital Innovations Group
Trident Digital Tech Holdings takes a strategic equity stake in Digital Innovations Group, becoming its commercializatio
Magnificent 7 Stocks Hit Decade-Low Valuation Premium Over S&P 500
Stocks
Magnificent 7 Stocks Hit Decade-Low Valuation Premium Over S&P 500
The Magnificent 7 stocks are trading at their cheapest relative to the S&P 500 in about 10 years, with a valuation premi
Micron, AMD, Intel Lead Premarket Chip Rebound as Analysts Reaffirm AI Demand Thesis
Stocks
Micron, AMD, Intel Lead Premarket Chip Rebound as Analysts Reaffirm AI Demand Thesis
Micron, AMD, and Intel surged in premarket trading Thursday as analysts raised price targets, signaling the AI chip sell
AstraZeneca Shares Tumble 9.5% as Wainua Fails Key Heart Disease Trial
Breaking
AstraZeneca Shares Tumble 9.5% as Wainua Fails Key Heart Disease Trial
AstraZeneca shares plunged 9.5% after Wainua failed to reduce cardiovascular events in a late-stage ATTR-CM trial, casti
SK Hynix ADR Draws Over 7x Demand, Poised for Record $28B US Listing
Stocks
SK Hynix ADR Draws Over 7x Demand, Poised for Record $28B US Listing
SK Hynix's ADR offering drew over seven times demand, with 1,000 institutional investors participating. The $28B Nasdaq
California Leads Antitrust Challenge to Paramount's $110B Warner Bros. Merger
Stocks
California Leads Antitrust Challenge to Paramount's $110B Warner Bros. Merger
A coalition of US states, led by California, is preparing an antitrust lawsuit to block Paramount's $110B acquisition of
Luxshare Precision Slumps 5% on Hong Kong Debut Despite $3B AI-Linked IPO
Stocks
Luxshare Precision Slumps 5% on Hong Kong Debut Despite $3B AI-Linked IPO
Luxshare Precision's Hong Kong debut slid over 5% despite pricing at the top of its range and raising $3.09B, signaling
MasTec Shares Surge 6% on $1.65B Superior Deal to Expand AI Data Center Reach
Stocks
MasTec Shares Surge 6% on $1.65B Superior Deal to Expand AI Data Center Reach
MasTec shares jumped 6% after announcing a $1.65 billion acquisition of electrical contractor Superior Group, expanding
FCEL vs BE: Why Bloom Energy Outshines FuelCell on Today's Dip
Stocks
FCEL vs BE: Why Bloom Energy Outshines FuelCell on Today's Dip
FuelCell Energy slides on a dilutive $225M offering, while Bloom Energy dips on macro-driven profit-taking. Despite both